Mphasis has announced a board meeting scheduled for October 30, 2025, to approve the standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 (Q2-FY26). The company will also host an earnings conference call. The trading window for designated persons remains closed from September 23, 2025, to November 1, 2025, and will reopen on November 2, 2025.
Board Meeting for Q2-FY26 Results
Mphasis has scheduled a meeting of its Board of Directors to be held on October 30, 2025. The primary agenda of the meeting is to review and approve the audited standalone and consolidated financial results for Q2-FY26, which ended on September 30, 2025. The meeting will also cover other general corporate matters.
Trading Window Closure
In compliance with the company’s Code of Conduct for Prevention of Insider Trading, the trading window for designated persons remains closed from September 23, 2025 to November 1, 2025. The trading window will reopen for trading on November 2, 2025.
Earnings Conference Call
Mphasis will schedule an Earnings Conference Call to discuss the Q2-FY26 financial results. The details of the call will be communicated separately in due course.
Source: BSE
